Clinical Trials · NCT02417142
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Massachusetts, Worcester
- Enrollment
- 70
- Start date
- Sep 2014
- Locations
- 1 site, United States
- Primary endpoint
- Negative Symptoms as Measured by the Scale for the Assessment of Negative Symptoms (SANS) Total Score